ArticleClinical and experimental hepatology2025
Does thyroid function disorder play a vital role in the pathogenesis of neonatal cholestasis?
Article in Clinical and experimental hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neonatal cholestasis is a syndrome characterized by decreased bile flow in infants and has several underlying causes, including genetic and metabolic diseases. Thyroid dysfunction may contribute to the pathophysiology of cholestasis, although it is not often acknowledged as a major cause. Further research into this possible connection is necessary because studies have linked thyroid conditions, including hyperthyroidism and euthyroid sick syndrome, to liver damage in newborns. This study aimed to evaluate the thyroid function in infants with neonatal cholestasis and determine whether it has a role in the diagnosis of other causes of neonatal cholestasis. Material and methods: The study included 100 infants with neonatal cholestasis of different causes (50 infants with biliary atresia [BA] and 50 infants with other causes of neonatal cholestasis other than BA) attending the National Liver Institute, Menoufia University, between July 2024 and January 2025. The infants were evaluated for serum free triiodothyronine (T3), free tetraiodothyronine (T4), and thyroid-stimulating hormone (TSH). Results: T3 was significantly higher in the non-BA group (3.97 ±0.45) than the BA group ( Conclusions: The results demonstrated significant differences in T3 levels, with higher levels observed in the non-BA group, while T4 and TSH showed no significant differences between the two groups. These findings suggest that thyroid dysfunction may be associated with neonatal cholestasis, particularly in conditions other than BA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.